Coral Laboratories Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Mumbai, Maharashtra and currently employs 109 full-time employees. The firm is engaged in the manufacturing of pharmaceutical formulations. The firm operates through Formulations segment. Its product portfolio includes non-sterile, sterile, nutraceutical and OTC + lifestyle. The firm's dosage forms include tablets, capsules, ointment and creams, liquid orals, b-lactam, topical preparations, eye/ear drops, nasal sprays, dry syrup, gels and lotions, injections (liquids and powder), granules powder, dry syrup, suppositories, and B-lactam among others. The company offers its products in various therapeutic areas, including antibiotics/antibacterial, anti-fungal, gastro-intestinal drugs, anti-emetics, analgesic/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, antiprotozoal/antiamoebic, anti-cold, herbal medicine, topical preparations, appetizer, oral antiseptic preparations, antimalarial drugs, cough suppressant/expectorant and mouthwash.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.